###### Strengths and limitations of this study

-   The present study examined the most thorough indices of fat distribution measured by a dual energy X-ray absorptiometry.

-   Smoking status was evaluated using the Fagerström Test for Nicotine Dependence, which is more consistent with the biochemical markers of heaviness of smoking.

-   This study does not establish any causal association between nicotine dependence and fat distribution for the cross-sectional study design.

-   The energy intake was not taken into adjustment in this study.

Introduction {#s1}
============

Smoking is of a significant single cause of the preventable mortality in the world,[@R1] and has been found to closely relate to body weight.[@R2] However, results from the previous studies have been complicated. When compared with non-smokers, current smokers tend to have lower body weight and body mass index (BMI); and smoking cessation can lead to weight gain.[@R2] However, neither body weight nor BMI can properly indicate central fat distribution, which is considered a discriminator of a cluster of chronic diseases. As current smokers tend to have greater waist circumference (WC), waist-to-hip ratio (WHR) and higher prevalence of central obesity,[@R2] it is important to consider body fat distribution in investigation the relationship between smoking and obesity.[@R8]

Most previous population-based studies used anthropometric indicators (eg, WC, WHR) to assess central fat distribution but these markers only indicate crude measurements of regional fat distribution. In order to capture a more precise association between smoking and body fat distribution, the dual energy X-ray absorptiometry (DXA) is utilised as a reliable measuring tool for both central and peripheral fat distribution.[@R11]

Self-reported exposure is the most commonly used method in a large scaled population-based study to evaluate the exposure to cigarette smoking. While the number of cigarettes smoked per day was the most frequently asked question in previous studies, it was not accurate for smoking assessment.[@R15] For example, saliva nicotine is a biochemical marker to assess the exposure to smoking, and over half of the variance of saliva nicotine depends on the factors other than the number of smoked cigarettes, including smoking depth and duration of inhalation, number of puffs per cigarette, and tapering of ventilation holes, and so on.[@R15] The Fagerström Test for Nicotine Dependence (FTND) is a standard test to assess nicotine dependence of current smokers and has a high-level consistency with biochemical indices of heaviness of smoking.[@R18] To our knowledge, the quantitative assessment of the direction and strength of nicotine dependence on body fat distribution has been poorly documented. Previous studies have not used FTND as an independent variable to quantitatively assess the association with fat distribution.

Therefore, this study aimed to investigate the association between fat distribution and smoking using the method of FTND in order to provide a complete profile of the associations of smoking with whole body fat distribution, including central and peripheral fat distribution.

Methods {#s2}
=======

Patient and public involvement {#s2a}
------------------------------

Patients were not involved in the design or conduct of this study. The results on physical examination, body composition and blood test were integrated into a brief health report to each participant.

Participants {#s2b}
------------

The study was conducted in 2015 in Lanxi, Zhejiang Province, China. Convenience sampling was performed to recruit participants. Extensive publicity campaigns included banner, poster, advertisement and radio. Invitation letters were delivered door-to-door by community leaders and health workers. Consent forms were collected from all the participants.

A total of 1264 male adults, aged 18--80 years old, were recruited in the study. All the participants joined this study voluntarily and gave consent for their health information to be used in the further studies. Participants who had missing information (n=63) or did not take DXA scan (n=30) were excluded, leading to an overall 1184 participants in the final analyses.

Anthropometry and DXA {#s2c}
---------------------

Weight and standing height were measured in light clothing without shoes to the nearest 0.01 kg and 0.1 cm, respectively. WC and hip circumference (HC) were measured using plastic flexible measuring tape to the nearest 0.1 cm (SECA 201, DE). WC was measured at the midpoint between the lower margin of the last palpable rib and the top of the iliac crest,[@R19] and HC was defined as the circumference of the widest portion of the buttocks, with the tape parallel to the floor.[@R19] All anthropometric values were measured three times and their mean was recorded. BMI, WHR and waist-to-height ratio (WHtR) were calculated and used as rough indicators of central obesity.

Total body fat mass (FM) and regional FM were measured utilising a whole-body scan with the DXA (GE-Lunar Prodigy, USA). For the android region, the upper boundary is above the pelvis cut by 20% of the distance between pelvis and femoral neck cuts and the lower boundary is at the pelvis cut.[@R20] The gynoid region was defined as the upper boundary below the pelvis cut line by 1.5 times the height of the android region. The height is equal to two times the height of the android region, and the lateral boundaries are the outer leg cuts.[@R20] The android and gynoid FM indicate abdominal and hip fat distribution, respectively.[@R20] The per cent of body fat mass (%BF) was calculated as a body fat mass divided by a total body weight. The per cents of trunk fat mass (%TF), arm fat mass (%ArmF), leg fat mass (%LegF), android fat mass (%AF) and gynoid fat mass (%GF) were calculated as trunk FM, android FM, gynoid FM, arm FM and leg FM divided by total body FM, respectively. The percent of limb fat mass (%LimbF) was calculated as the sum of %ArmF and %LegF. Android-to-gynoid fat mass ratio (AOI) was calculated as android FM divided by gynoid FM.

All the measurements above were assessed and calculated by trained staff from the Zhejiang University, Hangzhou, China, following the standardised protocol. The DXA was calibrated before each use against a standard phantom provided by the manufacturer.

Questionnaire survey {#s2d}
--------------------

All the participants were asked to complete a questionnaire that included demographic information, data on lifestyle and medical history. The questionnaire surveys were interviewed by trained personnel using an iPad-based direct data-entry system, with the function to avoid logical errors.

Marital status was categorised into two groups: married and others (unmarried, divorced or widowed). Education was classified into four levels: illiteracy, primary school, middle/high school and college or above. Alcohol use was categorised into two groups: regular (≥1/month currently) and others (\<1/month currently or never/former drinkers). Physical activity was assessed using a short version of the International Physical Activity Questionnaire. Based on the tertiled metabolic equivalence tasks, physical activity was classified into low, moderate and high groups.

A validated FTND (Chinese version) was applied to assess nicotine dependence, using scores of nicotine dependence ranging from 0 to 10. Based on self-reported smoking habits and FTND scores, participants were categorised into five groups of smoking status: non-smokers, former and current smokers with very low, low/moderate and high FTND scores. Non-smokers were defined as those who never smoked or those who had smoked no more than 100 cigarettes in their lifetime. Former smokers were those who quitted smoking for 6 months or longer and did not smoke currently. Current smokers were those who had smoked 100 cigarettes or more in their lifetime and currently smoked daily or occasionally, and were categorised into three subgroups based on the FTND scores: very low (scores of 0--2), low and moderate (scores of 3--5) and high (scores of 6--10) nicotine dependence.[@R18]

Physical examination {#s2e}
--------------------

After fasting for 12 hours overnight, venepuncture was conducted to measure participants' fasting plasma glucose, triglyceride, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and blood uric acid. A certificated clinical laboratory analysed the blood samples. Blood pressure was measured at least twice by trained staff using an auscultation mercury sphygmomanometre. The average value of the two recorded measurements was used.

Results of the physical examination were combined with individual medical history to determine the presence of the four main metabolic conditions: dysarteriotony, pathoglycaemia, dyslipidaemia and hyperuricaemia. Participants with at least one of the four main metabolic conditions were defined as metabolically abnormal.

Data analysis {#s2f}
-------------

Continuous and categorical variables were presented as mean (SD) and numbers (proportions), respectively. Characteristics of participants were compared by analysis of variance for continuous variables or by χ^2^ test for categorical variables among the groups of smoking status.

Multivariable linear regression models were applied to compare fat distribution within the five groups of smoking status. The adjustment variables included age, BMI, marital status, education, alcohol use and metabolic abnormality. To further explore the associations between fat distribution and FTND scores (continuous variable), multivariable linear regression models were conducted among all current smokers. Due to the significant interactions between age and FTND scores for %AF and AOI (data not shown), current smokers were stratified by age using 10-year intervals into four age groups and analysed separately. All the multivariable linear regression models were adjusted for age, BMI, marital status, education, physical activity, alcohol use and metabolic abnormality. A sensitivity analysis was performed by including participants with missing variables, encoded as mean for continuous and mode for categorical variables.

All the analyses were performed using SPSS V.20.0 (IBM, Armonk, New York, USA). P\<0.05 (two-tailed) was considered statistically significant.

Results {#s3}
=======

Basic characteristics of the participants {#s3a}
-----------------------------------------

The characteristics of the participants by smoking status are presented in [table 1](#T1){ref-type="table"}. Among the 1184 participants, the mean age, BMI and BF% were 53.57**±**13.53 years, 23.74**±**3.11 kg/m^2^ and 23.62%**±**6.29%, respectively. There were 520 non-smokers, 488 current smokers and 176 former smokers in total participants. Among the current smokers, the numbers of the smokers with very low, low/middle and high FTND were 241, 170 and 77, respectively. Significant differences in age, marital status, education, physical activity, height, HC, WHR, %AF and AOI (all p\<0.05) were found among the five groups of smoking. Current smokers with high FTND scores had the greatest WHR, %AF and AOI, and smallest HC.

###### 

The characteristics of the participants by smoking status and FTND scores (n=1184)

  Variables                  Mean±SD or N (%)   P value\*                                                             
  -------------------------- ------------------ ------------- ------------- ------------- ------------- ------------- ---------
  Age, years                 53.57±13.53        51.74±14.79   53.13±12.28   52.56±12.63   55.61±10.55   59.66±11.38   \<0.001
  Marital status                                                                                                      
   Married                   1090 (92.1)        462 (88.8)    232 (96.3)    154 (90.6)    73 (94.8)     169 (96.0)    0.001
   Others†                   94 (7.9)           58 (11.2)     9 (3.7)       16 (9.4)      4 (5.2)       7 (4.0)       
  Education                                                                                                           
   Illiteracy                94 (7.9)           32 (6.2)      18 (7.5)      21 (12.4)     11 (14.3)     12 (6.8)      \<0.001
   Primary                   173 (14.6)         61 (11.7)     34 (14.1)     20 (11.8)     15 (19.5)     43 (24.4)     
   Middle                    688 (58.1)         297 (57.1)    148 (61.4)    106 (62.4)    43 (55.8)     94 (53.4)     
   College or above          229 (19.3)         130 (25.0)    41 (17.0)     23 (13.5)     8 (10.4)      27 (15.3)     
  Physical activity                                                                                                   
   Low                       303 (25.6)         124 (23.8)    79 (32.8)     49 (28.8)     27 (35.1)     24 (13.6)     0.001
   Middle                    624 (52.7)         286 (55.0)    117 (48.5)    81 (47.6)     33 (42.9)     107 (60.8)    
   High                      257 (21.7)         110 (21.2)    45 (18.7)     40 (23.5)     17 (22.1)     45 (25.6)     
  Drinking status                                                                                                     
   Regular                   523 (44.2)         199 (38.3)    124 (51.5)    84 (49.4)     45 (58.4)     71 (40.3)     \<0.001
   Others‡                   661 (55.8)         321 (61.7)    117 (48.5)    86 (50.6)     32 (41.6)     105 (59.7)    
  Metabolic abnormality                                                                                               
   Normal                    215 (18.2)         105 (20.2)    42 (17.4)     26 (15.3)     13 (16.9)     29 (16.5)     0.576
   Abnormal                  969 (81.8)         415 (79.8)    199 (82.6)    144 (84.7)    64 (83.1)     147 (83.5)    
  FTND                       N/A                N/A           0.97±0.77     3.77±0.81     6.92±1.12     N/A           \<0.001
  Height, cm                 167.48±5.55        167.17±5.84   167.90±5.09   168.34±5.13   168.16±4.75   166.72±5.85   0.021
  Weight, kg                 66.65±9.76         66.70±9.82    67.46±9.74    66.83±9.78    65.67±9.32    65.65±9.77    0.360
  Body mass index, kg/m^2^   23.74±3.11         23.86±3.23    23.92±3.17    23.55±3.06    23.17±2.73    23.55±2.86    0.256
  Waist circumference, cm    86.01±9.15         85.84±9.48    86.39±9.13    85.88±9.04    86.81±8.03    85.79±8.85    0.859
  Hip circumference, cm      92.21±5.56         92.68±5.64    92.25±5.58    92.00±5.43    91.13±5.04    91.48±5.55    0.041
  Waist-to-hip ratio         0.93±0.07          0.92±0.07     0.93±0.06     0.93±0.06     0.95±0.06     0.94±0.06     0.005
  Waist-to-height ratio      0.51±0.05          0.51±0.06     0.51±0.05     0.51±0.05     0.52±0.05     0.51±0.05     0.923
  Body fat percentage        23.62±6.29         24.04±6.43    23.69±6.11    22.65±6.67    22.78±5.91    23.60±5.82    0.102
  Regional fat percentage                                                                                             
   Trunk                     61.84±4.92         61.66±5.12    62.22±4.65    61.56±4.74    62.84±4.45    61.68±5.03    0.197
   Arms                      8.85±1.28          8.87±1.32     8.77±1.22     8.82±1.19     8.82±1.38     8.95±1.30     0.675
   Legs                      24.94±4.34         25.14±4.63    24.67±4.02    25.13±4.10    23.89±3.74    24.97±4.35    0.138
   Limbs                     33.79±4.38         34.02±4.61    33.43±4.09    33.95±4.14    32.71±3.92    33.92±4.45    0.089
   Android                   11.69±1.28         11.58±1.31    11.81±1.24    11.72±1.20    12.19±1.18    11.62±1.30    0.001
   Gynoid                    15.81±2.84         15.96±2.95    15.61±2.76    16.08±2.83    15.23±2.44    15.64±2.78    0.090
  Android-to-gynoid ratio    0.77±0.19          0.76±0.19     0.79±0.18     0.76±0.18     0.83±0.18     0.77±0.18     0.022

\*Analysis of variance test for continuous variables and χ ^2^test for categorical variables among the groups of smoking status.

†Others: unmarried, divorced or widowed.

‡Others: \<1/month currently or never/former drinkers.

FTND, Fagerström Test for Nicotine Dependence; N/A, not applicable.

Association between smoking status and fat distribution {#s3b}
-------------------------------------------------------

The results of multivariable linear regression analysis by smoking status are presented in [table 2](#T2){ref-type="table"}. All regression models were adjusted for age, BMI, marital status, education, physical activity, alcohol use and metabolic abnormality. Compared with non-smokers, current smokers with high FTND scores had significantly higher values of WC, WHR, WHtR, %TF, %AF and AOI, and lower %LegF, %LimbF and %GF (all *β*\>0 and p*\<*0.05). Meanwhile, current smokers with low/moderate FTND scores had significantly greater values of WHR (*β*=0.08) and lower %BF (*β*=−0.806) compared with non-smokers.

###### 

Multivariable linear regression models\* on the association between smoking status and the indices of fat distribution in the whole participants (n=1184)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                 Non-smokers\   Very low FTND\   Low/mid FTND\              High FTND\   Former smokers\                                                                                    
                            (n=520)        (n=241)          (n=170)                    (n=77)       (n=176)                                                                                            
  ------------------------- -------------- ---------------- -------------------------- ------------ -------------------------- ------- -------------------------- --------- -------------------------- -------
  Waist circumference       Ref.                            0.159 (−0.463 to 0.782)    0.615        0.690 (−0.014 to 1.394)    0.055   2.362 (1.386 to 3.338)     \<0.001   −0.008 (−0.712 to 0.696)   0.982

  Hip circumference         Ref.                            −0.336 (−0.802 to 0.129)   0.157        −0.039 (−0.566 to 0.487)   0.883   −0.176 (−0.906 to 0.555)   0.637     −0.437 (−0.963 to 0.090)   0.104

  Waist-to-hip ratio        Ref.                            0.005 (−0.002 to 0.012)    0.165        0.008 (0.001 to 0.016)     0.049   0.028 (0.017 to 0.039)     \<0.001   0.004 (-0.003 to 0.012)    0.266

  Waist-to-height ratio     Ref.                            −0.002 (−0.006 to 0.001)   0.213        0.000 (−0.004 to 0.004)    0.893   0.009 (0.003 to 0.014)     0.002     −0.001 (-0.005 to 0.002)   0.458

  Body fat percentage       Ref.                            −0.321 (−0.933 to 0.291)   0.304        −0.806 (−1.499 to 0.113)   0.023   0.013 (−0.947 to 0.974)    0.978     −0.090 (-0.782 to 0.603)   0.799

  Regional fat percentage                                                                                                                                                                              

   Trunk                    Ref.                            0.085 (−0.518 to 0.688)    0.782        −0.205 (−0.887 to 0.477)   0.566   1.145 (0.199 to 2.091)     0.018     −0.202 (-0.884 to 0.480)   0.561

   Arms                     Ref.                            −0.094 (−0.288 to 0.099)   0.340        −0.031 (−0.251 to 0.188)   0.779   0.001 (−0.303 to 0.306)    0.993     −0.005 (-0.225 to 0.214)   0.962

   Legs                     Ref.                            −0.029 (−0.570 to 0.512)   0.915        0.129 (−0.484 to 0.741)    0.680   −1.103 (−1.952 to 0.254)   0.011     0.191 (-0.421 to 0.803)    0.540

   Limbs                    Ref.                            −0.124 (−0.696 to 0.448)   0.672        0.097 (−0.551 to 0.745)    0.768   −1.102 (−2.000 to 0.203)   0.016     0.186 (-0.462 to 0.833)    0.574

   Android                  Ref.                            0.125 (−0.055 to 0.305)    0.173        0.077 (−0.127 to 0.281)    0.460   0.541 (0.259 to 0.824)     \<0.001   −0.044 (-0.248 to 0.160)   0.669

   Gynoid                   Ref.                            −0.124 (−0.432 to 0.184)   0.429        0.102 (−0.247 to 0.451)    0.566   −0.796 (−1.279 to 0.312)   0.001     0.013\                     0.941
                                                                                                                                                                            (−0.335 to 0.362)          

  Android-to-gynoid ratio   Ref.                            0.010 (−0.012 to 0.033)    0.373        −0.004 (−0.030 to 0.022)   0.747   0.063 (0.027 to 0.098)     0.001     −0.008 (−0.34 to 0.017)    0.529
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Adjusted for age, body mass index, marital status, education, physical activity, drinking status and metabolic abnormality.

FTND, Fagerström Test for Nicotine Dependence.

Association between FTND scores and fat distribution {#s3c}
----------------------------------------------------

The results of multivariable linear regression models on FTND scores and fat distribution in total current smokers and in each age group of current smokers are presented in [table 3](#T3){ref-type="table"}. After adjusting for age, BMI, marital status, education, physical activity, alcohol use and metabolic abnormality in the current smokers, the FTND scores only showed significantly positive associations with WC, WHR and WHtR among total current smokers (all *β*\>0 and p*\<*0.05). When stratifying age to four layers, the FTND scores had significantly positive associations with WC, WHR, WHtR, %TF, %AF and AOI (all *β*\>0 and p*\<*0.05), and significantly negative associations with %LegF, %LimbF and %GF (all *β*\<0 and p*\<*0.05) in the group of 60 years or older current smokers. However, in the groups of 40--49 and 50--59 years old current smokers, FTND scores were positively associated with WC only (*β*=0.268 for 40--49 years and *β*=0.350 for 50--59 years).

###### 

Multivariable linear regression models\* on the association between FTND scores and the indices of fat distribution in the whole and each age group of current smokers (n=488)

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                 Total current smokers\     Age\<40\   40≤age≤49\                 50≤age≤59\   Age≥60\                                                                                          
                            (n=488)                    (n=66)     (n=123)                    (n=129）     (n=170）                                                                                         
  ------------------------- -------------------------- ---------- -------------------------- ------------ -------------------------- ------- -------------------------- ------- -------------------------- ---------
  Waist circumference       0.314 (0.169 to 0.460)     \<0.001    0.291 (−0.121 to 0.703)    0.163        0.268 (0.005 to 0.531)     0.046   0.350 (0.043 to 0.658)     0.026   0.481 (0.221 to 0.741)     \<0.001

  Hip circumference         0.062 (−0.045 to 0.170)    0.257      0.122 (−0.234 to 0.478)    0.496        0.146 (−0.082 to 0.374)    0.208   0.082 (−0.153 to 0.316)    0.491   0.022 (−0.149 to 0.193)    0.799

  Waist-to-hip ratio        0.003 (0.001 to 0.005)     0.001      0.002 (−0.003 to 0.007)    0.452        0.001 (−0.002 to 0.005)    0.421   0.003 (0.000 to 0.007)     0.111   0.006 (0.002 to 0.009)     \<0.001

  Waist-to-height ratio     0.001 (0.001 to 0.002)     0.001      0.000 (−0.002 to 0.003)    0.892        0.001 (0.000 to 0.003)     0.151   0.002 (0.000 to 0.003)     0.056   0.002 (0.001 to 0.004)     0.001

  Body fat percentage       0.029 (−0.119 to 0.176)    0.702      0.115 (−0.417 to 0.647)    0.667        0.020 (−0.250 to 0.290)    0.883   0.016 (−0.296 to 0.329)    0.918   0.161 (−0.088 to 0.410)    0.204

  Regional fat percentage                                                                                                                                                                                  

   Trunk                    0.077 (−0.069 to 0.222)    0.302      0.000 (−0.429 to 0.428)    0.998        −0.052 (−0.320 to 0.215)   0.699   −0.138 (−0.421 to 0.145)   0.335   0.350 (0.072 to 0.628)     0.014

   Arms                     0.010 (−0.037 to 0.057)    0.665      −0.082 (−0.255 to 0.091)   0.348        −0.005 (−0.093 to 0.083)   0.905   0.083 (−0.012 to 0.177)    0.085   −0.003 (−0.085 to 0.078)   0.933

   Legs                     −0.076 (−0.205 to 0.054)   0.253      0.108 (−0.318 to 0.533)    0.614        0.037 (−0.195 to 0.268)    0.754   0.025 (−0.215 to 0.266)    0.835   −0.276 (−0.531 to 0.021)   0.034

   Limbs                    −0.065 (−0.204 to 0.073)   0.356      0.026 (−0.392 to 0.444)    0.901        0.031 (−0.229 to 0.292)    0.811   0.108 (−0.156 to 0.372)    0.418   −0.279 (−0.545 to 0.013)   0.040

   Android                  0.038 (−0.007 to 0.083)    0.095      −0.061 (−0.187 to 0.066)   0.339        −0.021 (−0.094 to 0.052)   0.561   0.000 (−0.084 to 0.082)    0.983   0.149 (0.058 to 0.240)     0.002

   Gynoid                   −0.052 (−0.128 to 0.025)   0.185      0.008 (−0.217 to 0.234)    0.941        0.003 (−0.117 to 0.123)    0.964   0.033 (−0.118 to 0.185)    0.663   −0.199 (−0.357 to 0.042)   0.014

  Android-to-gynoid ratio   0.004 (−0.002 to 0.009)    0.214      −0.007 (−0.023 to 0.008)   0.354        −0.003 (−0.012 to 0.006)   0.568   0.000 (−0.011 to 0.011)    0.935   0.016 (0.005 to 0.028)     0.006
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Adjusted for age, body mass index, marital status, education, physical activity, drinking status and metabolic abnormality.

FTND, Fagerström Test for Nicotine Dependence.

Additionally, the results showed no significant differences between included and excluded participants with missing variables.

Discussion {#s4}
==========

The present study found that current smokers with high FTND scores had greater values of WC, WHR, WHtR, %TF, %AF and AOI, and lower %LegF, %LimbF and %GF compared with non-smokers after controlling for age, BMI and other potential confounding factors. The current smokers, particularly 60 years or older current smokers, had FTND scores positively associated with central fat distribution and inversely associated with peripheral fat distribution.

Previous studies demonstrated that smoking was associated with central fat distribution using anthropometric indicators (eg, WC and WHR) alone.[@R2] Consistent with previous study, the association between smoking status and fat distribution in this study population showed that heavy smokers had more central fat than non-smokers.[@R23] In the age stratification analyses, stronger associations between FTND scores and fat distribution were found in the current smokers with older age, which is consistent with previous studies.[@R6]

The effect of smoking on fat distribution is a chronic dose-response process.[@R24] High nicotine dependence or age often implicate a heavier and longer exposure to smoking, thus the associations of smoking with fat distribution are likely to be observed in older or heavy smokers. As the number of younger current smokers was limited in this study, it might restrict the power to examine significant associations between smoking and fat distribution.

Compared with the previous population-based studies, this study examined the most thorough indices of fat distribution and provided a complete profile of the associations between smoking and whole-body fat distribution, including central and peripheral fat distribution. Using the DXA to measure fat distribution provided concise evidence to detect the changes in peripheral fat distribution in older or heavier smokers. Declined peripheral fat distribution might be the reason to weight loss and declined BMI in some smokers reported from the previous studies. Considering the single racial composition of the participants, the study's findings can be only applied to East Asians, and more multiracial evidence is in need for better generalisability. Given the similar BMI, Asians tend to have more central fat distribution than Caucasians do,[@R26] suggesting that association between fat distribution and smoking might have an ethnical-specific importance for Asians. Additionally, the associations between smoking, muscle loss and sarcopenia were also reported elsewhere.[@R27] However, studies on the association between nicotine dependence and skeletal muscle mass are limited and requires further evidence.

Despite that smoking is known to associate with body weight and fat distribution, the underlying biological mechanism remains unclear. It is mainly because nicotine acts at different organs and tissues in human body. Some noticeable hormones and internal secretions might be part of the physiological pathways between smoking and fat distribution. Cortisol concentrations are higher in smokers because of the stimulation of sympathetic nervous system activity induced by smoking.[@R24] Experiment in vivo showed depot-specific response to high cortisol concentrations in the abdominal and gluteofemoral depots.[@R28] Meanwhile, previous studies have found that high-dose nicotine induces higher cortisol concentrations in male smokers,[@R29] which might explain the mechanism of the associations between FTND score with central and peripheral fat distribution. Insulin resistance, a risk indicator for increased central adiposity, is considered to directly and independently relate to smoking.[@R24] For male smokers, smoking may reduce testosterone concentrations, which is inversely associated with visceral fat mass.[@R24] Moreover, adiponectin and leptin are associated with body fat distribution and have different concentrations between smokers and non-smokers.[@R31] In summary, a number of physiological factors affect associations between smoking and body fat distribution, but the network of these factors have not been well understood and more evidence is needed in the future.

There are several limitations in our study. First, the inherent limitation of the cross-sectional study is that it does not establish any temporal or causal association between nicotine dependence and fat distribution. The small sample size of subgroup might restrict the clinical importance of this study and further evidence from longitudinal studies is required. Second, potential self-report bias may exist in assessment of smoking exposure. However, FTND has a high level consistency with biochemical indices of heaviness of smoking, and is a reliable tool to evaluate nicotine dependence.[@R18] Third, energy intake was not adjusted in the model, which might attenuate findings. However, it is well documented that nicotine suppressed appetite, reduced energy intake and increased energy expenditure,[@R34] which inversely associated with abdominal obesity.[@R36] We assumed that nicotine dependence was negatively associated with energy intake, and that adjustment for energy intake might not change the direction of findings. Meanwhile, we did not collect the type or dosage of alcohol use in this study, which should be improved in the future study.

Conclusion {#s5}
==========

This study shows a positive association between nicotine dependence and central fat distribution, and an inverse association between nicotine dependence and peripheral fat distribution. Both associations were independent of BMI in Chinese male adults, particularly for older or high FTND smokers.
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